Literature DB >> 9699721

Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas.

C P Tensen1, M H Vermeer, P M van der Stoop, P van Beek, R J Scheper, D M Boorsma, R Willemze.   

Abstract

Epidermal infiltration by neoplastic CD4+ T cells is a characteristic histologic feature of early stage mycosis fungoides, the most common type of cutaneous T cell lymphoma (CTCL). The mechanisms involved in epidermotropism are unknown. It has been suggested that the CXC chemokines IL-8 and interferon-gamma inducible protein 10 (IP-10) may play a role, but evidence that these chemokines are produced within the epidermis in epidermotropic CTCL is lacking. In this study skin biopsies from 17 CTCL patients, including 12 mycosis fungoides, four pleomorphic CTCL, and one CD8+ CTCL, were investigated for epidermal IL-8 and IP-10 mRNA expression by RNA in situ hybridization. In addition, the expression of monokine induced by gamma-interferon (Mig) mRNA, a CXC chemokine closely related to IP-10, was studied as well. The expression of IL-8 receptors A and B (CXCR1 and CXCR2, respectively) was investigated by immunohistochemistry. The results were correlated with the number and phenotype of epidermotropic T cells. Epidermal expression of IP-10 and Mig mRNA was detected in 10 of 11 and seven of 11 epidermotropic CTCL, respectively, but not in five nonepidermotropic CTCL biopsies or normal human skin. Epidermal IP-10 and Mig mRNA expression correlated with epidermal infiltration of CD4+ T cells, but not of CD8+ T cells. IL-8 mRNA was demonstrated in the epidermis of only two of 15 CTCL biopsies, and was associated, in both cases, with accumulation of neutrophils. Consistently, immunostaining of the (intraepidermal) T cells with antibodies against CXCR1 and CXCR2 was not observed. In conclusion, the results of this study indicate that IP-10, and to a lesser extent Mig, but not IL-8 is involved in the preferential infiltration of neoplastic CD4+ T cells in CTCL.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699721     DOI: 10.1046/j.1523-1747.1998.00263.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Distinct age-matched serum biomarker profiles in patients with cutaneous T-cell lymphoma.

Authors:  Larisa J Geskin; Oleg E Akilov; Yan Lin; Anna E Lokshin
Journal:  Exp Dermatol       Date:  2014-07-16       Impact factor: 3.960

2.  Pyoderma gangrenosum in a patient with cutaneous T-cell lymphoma.

Authors:  Randy Tang; Larisa Geskin; Marc E Grossman
Journal:  JAAD Case Rep       Date:  2015-03-27

Review 3.  CXCL9: evidence and contradictions for its role in tumor progression.

Authors:  Qiang Ding; Panpan Lu; Yujia Xia; Shuping Ding; Yuhui Fan; Xin Li; Ping Han; Jingmei Liu; Dean Tian; Mei Liu
Journal:  Cancer Med       Date:  2016-10-10       Impact factor: 4.452

Review 4.  Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover.

Authors:  Thorbjørn Krejsgaard; Lise M Lindahl; Nigel P Mongan; Mariusz A Wasik; Ivan V Litvinov; Lars Iversen; Erik Langhoff; Anders Woetmann; Niels Odum
Journal:  Semin Immunopathol       Date:  2016-10-07       Impact factor: 9.623

Review 5.  New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma.

Authors:  Kazuyasu Fujii
Journal:  Front Oncol       Date:  2018-06-04       Impact factor: 6.244

6.  Mycosis fungoides progression could be regulated by microRNAs.

Authors:  Rebeca Manso; Nerea Martínez-Magunacelaya; Itziar Eraña-Tomás; Verónica Monsalvez; José L Rodríguez-Peralto; Pablo-L Ortiz-Romero; Carlos Santonja; Ion Cristóbal; Miguel A Piris; Socorro M Rodríguez-Pinilla
Journal:  PLoS One       Date:  2018-06-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.